Keywords: Multiple Sclerosis, MS, Novartis, Extavia

Novartis Multiple sclerosis drug Extavia cleared by US FDA

Article | 17 August 2009

Print This

The US Food and Drug Administration (FDA) has approved Extavia (interferon beta-1b), the first in a new planned portfolio ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in